Finnish healthtech company Neuro Event Labs has raised €3.9m (US$4.3m) Series A funding from Hadean Ventures, SHS Capital and Maki.vc to support commercial expansion of its epilepsy diagnostics product. “Epilepsy is one of the most common neurological disorders, affecting more than 65 million individuals worldwide. To provide optimal treatment, it’s crucial to be able to…
©2020 All rights reserved LaingBuisson 
 Series A funding from Hadean Ventures,){kind=link}